基于位的特定抗体修饰
Saki Horie1, Kenji Mishiro2, Mio Nishino1
1Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan.
Bioconjugate chemistry
|October 20, 2023
概括
研究人员开发了一种新的方法,用于选择性抗体修饰,使用以表位基的亲和度标签. 这种技术允许针对性地修改抗体.
科学领域:
- 生物结合化学 生物结合化学
- 免疫学 免疫学 免疫学
- 蛋白质工程是指蛋白质工程.
背景情况:
- 改性抗体对于分析,诊断和治疗应用至关重要.
- 为了在修改过的抗体中获得最佳的物理和生物特性,需要对修改部位进行精确控制.
- 目前用于抗体修饰的方法在维持向亲和度方面经常面临挑战,特别是在修改表位结位时.
研究的目的:
- 开发一种针对Fab区域的选择性抗体修饰方法.
- 为了克服在抗体修饰后保持高表位亲和度的挑战.
- 建立一个高效和强大的抗体工程协议.
主要方法:
- 基于位的亲和度标签被用于选择性修改.
- 对修饰剂结构,反应条件和净化技术进行了广泛的选.
- 该方法侧重于修改抗体的碎片抗原结合 (Fab) 区域.
主要成果:
- 成功开发了一种选择性修改抗体Fab区域的高效方法.
- 开发的方法确保在修改后保持高表位亲和度.
- 反应参数和净化策略的优化是实现选择性和维护功能的关键.
结论:
- 使用优化表位基亲和性标记,可以实现对抗体Fab区域的选择性修饰.
- 这种方法为设计具有定制性质的抗体提供了有价值的工具,同时保留了它们的结合特异性.
- 开发的技术对推进基于抗体的诊断和治疗具有重大意义.
更多相关视频
08:09Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
9.6K
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.8K
相关概念视频
Affinity and Avidity
36.2K
Overview
36.2K
Antibody Structure
60.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.2K
Hybridoma Technology
14.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.8K
Antibody Structure and Classes
931
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
931
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Cross-reactivity
31.2K
Overview
31.2K
